Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms

被引:54
|
作者
Cocuaud, C [1 ]
Rodier, MH [1 ]
Daniault, G [1 ]
Imbert, C [1 ]
机构
[1] CHU La Miletrie, Lab Parasitol & Mycol Med, F-86021 Poitiers, France
关键词
candidiasis; catheters; antifungals; metabolism; echinocandins;
D O I
10.1093/jac/dki269
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Candidiasis can be associated with the formation of biofilms on bioprosthetic surfaces and the intrinsic resistance of Candida albicans biofilms to the most commonly used antifungal agents has been demonstrated. In this study, we report on the antifungal activity of caspofungin at two different concentrations, on C. albicans and Candida parapsilosis biofilms with different ages of maturation. Methods: Fifteen strains of C. albicans (10 strains susceptible to fluconazole in vitro and five strains resistant to this antifungal agent) and six strains of C. parapsilosis (all were susceptible to fluconazole in vitro) were studied. The antifungal activity of caspofungin was assessed by looking for a significant inhibition of the metabolic activity of yeasts within biofilms. Biofilms of Candida were produced in vitro, on silicone catheters. Results: Caspofungin used at MIC did not modify the metabolic activity of C. albicans, whatever the maturation age of the biofilms. The same concentration of caspofungin significantly reduced the metabolism (P <= 0.001) of 25% (biofilms of 48 h) to 50% (biofilms of 2 h) of the C. parapsilosis yeasts. The use of a therapeutic concentration of caspofungin (2 mg/L) significantly decreased (P <= 0.001) the metabolism of all the strains of C. albicans and C. parapsilosis tested, independently of the biofilm maturation age. This potent antifungal activity of caspofungin on C. albicans biofilms was observed independently of the yeast susceptibility to fluconazole. Conclusions: This study demonstrated that caspofungin used at MIC was not sufficient to reduce C. albicans biofilms, but it suggested an activity on C. parapsilosis biofilms depending on their maturation age. This study also indicated that caspofungin used at 2 mg/L could be a good candidate in the prevention of candidiasis associated with silicone medical devices. Our results also suggested that fluconazole resistance of yeasts did not affect caspofungin activity.
引用
下载
收藏
页码:507 / 512
页数:6
相关论文
共 50 条
  • [1] Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms
    Kovacs, R.
    Nagy, F.
    Toth, Z.
    Bozo, A.
    Balazs, B.
    Majoros, L.
    LETTERS IN APPLIED MICROBIOLOGY, 2019, 69 (04) : 271 - 278
  • [2] In vitro activity of caspofungin against Candida albicans biofilms
    Bachmann, SP
    VandeWalle, K
    Ramage, G
    Patterson, TF
    Wickes, BL
    Graybill, JR
    López-Ribot, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3591 - 3596
  • [3] Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades
    Gil-Alonso, Sandra
    Jauregizar, Nerea
    Eraso, Elena
    Quindos, Guillermo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (02) : 172 - 177
  • [4] Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity
    Marcos-Zambrano, L. J.
    Escribano, P.
    Bouza, E.
    Guinea, J.
    MYCOSES, 2015, 58 : 51 - 51
  • [5] In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation
    Prazynska, Malgorzata
    Bogiel, Tomasz
    Gospodarek-Komkowska, Eugenia
    FOLIA MICROBIOLOGICA, 2018, 63 (02) : 209 - 216
  • [6] In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation
    Małgorzata Prażyńska
    Tomasz Bogiel
    Eugenia Gospodarek-Komkowska
    Folia Microbiologica, 2018, 63 : 209 - 216
  • [7] Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis
    Varga, I.
    Soczo, G.
    Kardos, G.
    Borbely, A.
    Szabo, Zs.
    Kemeny-Beke, A.
    Majoros, L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1466 - 1468
  • [8] Effects of caspofungin against Candida guilliermondii and Candida parapsilosis
    Barchiesi, Francesco
    Spreghini, Elisabetta
    Tomassetti, Serena
    Della Vittoria, Agnese
    Arzeni, Daniela
    Manso, Esther
    Scalise, Giorgio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2719 - 2727
  • [9] Micafungin at Physiological Serum Concentrations Shows Antifungal Activity against Candida albicans and Candida parapsilosis Biofilms
    Guembe, M.
    Guinea, J.
    Marcos-Zambrano, L. J.
    Fernandez-Cruz, A.
    Pelaez, T.
    Munoz, P.
    Bouza, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5581 - 5584
  • [10] Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms
    Kovacs, R.
    Bozo, A.
    Doman, M.
    Nagy, F.
    Toth, Z.
    Majoros, L.
    MYCOSES, 2015, 58 : 79 - 80